Sonify Biosciences

Sonify Biosciences is developing a medical device based on low-intensity ultrasound as an early stage adjuvant therapy for skin cancer.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Baltimore, MD, USA
  • Currency USD
  • Founded April 2012
  • Employees 4
  • Website sonifybio.com

Company Summary

We are pioneering new medical devices and therapies based on low-intensity ultrasound to treat melanoma and other cancers in a targeted, effective, and affordable way. Low-intensity ultrasound is an effective non-chemical treatment in many areas, including against malignant melanoma. Our technology is being developed for those in need to increase positive patient outcomes while simultaneously driving down the cost of care.

Team

  • Miriam Boer
    CTO

    Miriam is the creative force behind Sonify. She received her PhD in Biochemistry from the University of Maryland in 2011 and her BA in Chemistry from New York University in 2005. She has significant expertise in membrane channel function, mechanosensation, and mammalian physiology. She has also worked with various DNA nanostructures and has spent time in industry working in color and flavor chemistry at PepsiCo’s International R&D.

  • Daniel Rogers
    Strategic Adviser

    Danny helps technology companies like Sonify take concepts and turn them into products and generally assists where needed. His proficiencies include but are not limited to everything from expertise in math and physics to business development and go-to-market strategies.

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free